Mrs. Petra M Buch, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 207 2nd St Sw, Rugby, ND 58368 Phone: 701-776-5757 |
Mrs. Colleen J. Hermanson, M.S. SLP-CCC Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 126 S Main Ave., Rugby, ND 58368 Phone: 701-208-1602 |
Horizons Speech Therapy Services, Llc Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 126 S Main Ave, Rugby, ND 58368 Phone: 701-208-1602 |
Ms. Skye F Carmichael Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 207 2nd St Sw, Rugby, ND 58368 Phone: 701-776-5757 |
News Archive
Although more than nine out of ten doctors believe it is appropriate to discuss religious or spiritual issues when a patient brings them up and three out of four encourage patients' religious beliefs and practices, only half inquire, even occasionally, about a patient's faith
Through an innovative feat of plant biotechnology and vaccine design, researchers in the Biodesign Institute at Arizona State University have successfully turned tobacco plants into vaccine production factories to combat the deadliest form
Although, in the majority of cases, the localized presence of Neisseria meningitidis in the throat has no consequence, it can sometimes lead to meningitis or septicaemia. The seriousness of these two infections is driving researchers from around the world to improve their understanding of the mode of operation of this bacterium, which, once it leaves its favourite location becomes extremely dangerous.
Micromet, Inc., a biopharmaceutical company focused on the development and commercialization of next-generation antibodies for the treatment of cancer, today announced that updates on several of its BiTE antibody development programs will be made at two upcoming medical conferences.
Med Data Quest, a pioneering medical informatics total solution provider, today celebrates its successful collaboration with the Oncology Business Unit of the CRO giant WuXi AppTec, delivering the world's first mobile App OncoWuXi that was launched in October for customers to access WuXi oncology tumor models and capabilities more quickly and easily for cancer drug discovery and translational research.
› Verified 9 days ago